Literature DB >> 14613466

Analysis of medication use patterns:apparent overuse of antibiotics and underuse of prescription drugs for asthma, depression, and CHF.

Karen Gilberg1, Marianne Laouri, Sally Wade, Sharon Isonaka.   

Abstract

OBJECTIVE: To assess the appropriateness of prescription medication use based upon widely accepted treatment guidelines.
METHODS: We analyzed administrative claims for the period October 1, 1998, through September 20, 1999, supplied by 3 California health plans to determine medication use patterns for outpatient prescriptions. We compared these patterns to those expected in the presence of adherence to treatment guidelines.
RESULTS: During the study period, only 27.5% of antidepressant users received the recommended 6 months of continuous therapy, only 49.0% of diagnosed asthma patients received at least one inhaled corticosteroid prescription (compared to 67.1% who received at least one inhaled beta-agonist prescription), and only 54.5% of patients diagnosed with congestive heart failure (CHF) received an angiotensin-converting enzyme (ACE) inhibitor. Of patients who had a diagnosis of common cold or upper respiratory tract infection, 35.7% received antibiotics.
CONCLUSION: There is a remarkable degree of apparent overuse and underuse of prescription medications despite the existence of clinical guidelines to support appropriate use in the conditions studied. Effective medications appear to be underused for patients with asthma, CHF, and depression. Antibiotics appear to be overused for the common cold and upper respiratory infections. More effective efforts must be made to address appropriate use of medications. Without these efforts, improved quality of care and decreased total health system costs are unlikely to be realized.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14613466     DOI: 10.18553/jmcp.2003.9.3.232

Source DB:  PubMed          Journal:  J Manag Care Pharm        ISSN: 1083-4087


  12 in total

1.  Prescription drug costs.

Authors:  Michael J Rieder; Marina Salvadori
Journal:  Paediatr Child Health       Date:  2004-10       Impact factor: 2.253

2.  Using spatial analysis to demonstrate the heterogeneity of the cardiovascular drug-prescribing pattern in Taiwan.

Authors:  Ching-Lan Cheng; Yi-Chi Chen; Tzu-Ming Liu; Yea-Huei Kao Yang
Journal:  BMC Public Health       Date:  2011-05-24       Impact factor: 3.295

Review 3.  Overuse of antidepressant drugs for the treatment of depression.

Authors:  Jon Jureidini; Anne Tonkin
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  The impact of medication nonadherence on the relationship between mortality risk and depression in heart failure.

Authors:  Emily C Gathright; Mary A Dolansky; John Gunstad; Joseph D Redle; Richard A Josephson; Shirley M Moore; Joel W Hughes
Journal:  Health Psychol       Date:  2017-07-20       Impact factor: 4.267

5.  Levalbuterol versus albuterol.

Authors:  Bill T Ameredes; William J Calhoun
Journal:  Curr Allergy Asthma Rep       Date:  2009-09       Impact factor: 4.806

6.  Adverse reactions associated with therapeutic antibiotic use after penicillin skin testing.

Authors:  Eric Macy; Ngoc J Ho
Journal:  Perm J       Date:  2011

7.  Antibiotic misuse among children with diarrhea in China: results from a national survey.

Authors:  Ruili Li; Feng Xiao; Xiaoguo Zheng; Huimin Yang; Lihong Wang; Delu Yin; Tao Yin; Qianqian Xin; Bowen Chen
Journal:  PeerJ       Date:  2016-11-03       Impact factor: 2.984

Review 8.  Carbon Quantum Dots Derived from Different Carbon Sources for Antibacterial Applications.

Authors:  Yanyan Wu; Cong Li; Henny C van der Mei; Henk J Busscher; Yijin Ren
Journal:  Antibiotics (Basel)       Date:  2021-05-24

9.  Antibiotics and allergic disorders in childhood.

Authors:  Sue Jordan; Mel Storey; Gareth Morgan
Journal:  Open Nurs J       Date:  2008-05-22

10.  Depression and drug utilization in an elderly population.

Authors:  Raffaele Antonelli Incalzi; Andrea Corsonello; Claudio Pedone; Francesco Corica; Pierugo Carbonin
Journal:  Ther Clin Risk Manag       Date:  2005-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.